TG THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
TG THERAPEUTICS, INC. (TGTX) reported Increase Decrease In Operating Lease Liability of -$832.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-05
- TG THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$408.00K.
- TG THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$424.00K.
- TG THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$519.00K.
- TG THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$519.00K.
- TG THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$2.10M.
- TG THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$2.39M.
- TG THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$2.38M.
- TG THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2022 was -$2.33M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$832.00K 10-Q · filed 2026-08-05 | -$1.35M derived: sum of 3 quarters · filed 2026-08-05 | -$1.87M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$424.00K 10-Q · filed 2026-05-06 | -$943.00K derived: sum of 2 quarters · filed 2026-05-06 | -$1.46M derived: sum of 3 quarters · filed 2026-05-06 | -$1.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.04M derived: sum of 2 quarters · filed 2026-02-27 | -$1.56M derived: sum of 3 quarters · filed 2026-08-05 | -$2.10M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$519.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.04M derived: sum of 2 quarters · filed 2026-08-05 | -$1.58M 10-Q · filed 2025-11-05 | -$2.18M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$518.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.06M 10-Q · filed 2026-08-05 | -$1.66M derived: sum of 3 quarters · filed 2026-08-05 | -$2.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$543.00K 10-Q · filed 2026-05-06 | -$1.14M derived: sum of 2 quarters · filed 2026-05-06 | -$1.74M derived: sum of 3 quarters · filed 2026-05-06 | -$2.33M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.20M derived: sum of 2 quarters · filed 2026-02-27 | -$1.79M derived: sum of 3 quarters · filed 2026-02-27 | -$2.39M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$597.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.19M derived: sum of 2 quarters · filed 2025-11-05 | -$1.79M 10-Q · filed 2025-11-05 | -$2.38M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$597.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$1.19M 10-Q · filed 2025-08-08 | -$1.79M derived: sum of 3 quarters · filed 2026-02-27 | -$2.38M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$596.00K 10-Q · filed 2025-05-09 | -$1.19M derived: sum of 2 quarters · filed 2026-02-27 | -$1.78M derived: sum of 3 quarters · filed 2026-02-27 | -$2.38M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.19M derived: sum of 2 quarters · filed 2026-02-27 | -$1.78M derived: sum of 3 quarters · filed 2026-02-27 | -$2.38M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$593.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.19M derived: sum of 2 quarters · filed 2024-11-07 | -$1.78M 10-Q · filed 2024-11-07 | -$2.37M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$594.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.19M 10-Q · filed 2024-08-09 | -$1.78M derived: sum of 3 quarters · filed 2025-03-03 | |
| 2023-03-31 | -$593.00K 10-Q · filed 2024-05-06 | -$1.18M derived: sum of 2 quarters · filed 2025-03-03 | ||
| 2022-12-31 | -$591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$2.33M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | -$1.74M 10-Q · filed 2023-11-06 | |||
| 2021-12-31 | -$2.01M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |